Could a Sit-Down MRI make prostate cancer screening easier?

NCT ID NCT03474913

Recruiting now Diagnosis Sponsor: Icahn School of Medicine at Mount Sinai Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether an upright MRI (where you sit) can detect prostate cancer as well as the standard closed MRI and PSA blood test. About 550 men at risk for prostate cancer will get both types of MRI and answer comfort questionnaires. The goal is to see if the upright MRI is a good, more comfortable screening option.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Upright MRI (Indomitable Magnetic Resonance Imaging Scanner, 0.6 T)
What this could lead to: If successful, this could offer a more comfortable and accessible MRI option for prostate cancer screening, potentially improving detection rates.
What could go wrong: This is an early feasibility study with 550 participants, so results may not apply to everyone. The upright MRI may not be as accurate as standard MRI, and it is not a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ELEVATED PROSTATE SPECIFIC ANTIGEN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

disease neoplasm prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ELEVATED PROSTATE SPECIFIC ANTIGEN ELEVATED PSA PROSTATE CANCER

Contacts and locations

Locations

Icahn School of Medicine at Mount Sinai
RECRUITING

New York, New York, 10029, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.